BIRC5 and non-small cell lung carcinoma: Derin et al. [25] investigated the concentrations of serum survivin protein by ELISA technique in advanced stage non-small cell lung cancer patients before and after cytostatic treatment, and they demonstrated a significant decrease in survivin levels in the chemoresponsive group.